{
  "pmcid": "11783632",
  "sha256": "bfb498c21e918889b366b432c7c83a0cfcf36beef609e173eaa3b204e72f1aad",
  "timestamp_utc": "2025-11-09T23:20:24.939615+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.907333333333337,
    "reading_ease": 17.79600000000002,
    "word_count": 252
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Chest Bioreactance and Calibrated Pulse Contour Analysis in Thoracic Cancer Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "prospective monocentre observational study included 50 adult patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a tertiary university hospital...Eligibility criteria included elective unilateral thoracic cancer surgery with PCA monitoring."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Simultaneous cardiac index (CI) measurements using bioreactance (CI-NICOM) and PCA calibrated by transthoracic echocardiography (CI-PCA)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the interchangeability of chest bioreactance and calibrated pulse contour analysis (PCA) for cardiac output measurement."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the interchangeability of CI-NICOM and CI-PCA, assessed by Bland–Altman analysis and percentage error calculation."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "50 adult patients undergoing thoracic cancer surgery"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "CI-PCA and CI-NICOM differed significantly: 2.4 ± 0.8 vs. 2.9 ± 0.9 l min −1 m −2, respectively (P < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT04251637."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}